Gilead Sciences Inc (NAS:GILD)
$ 67.86 0.865 (1.29%) Market Cap: 84.54 Bil Enterprise Value: 105.02 Bil PE Ratio: 188.50 PB Ratio: 4.82 GF Score: 77/100

Gilead Sciences Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2022 / 04:15PM GMT
Release Date Price: $72.09 (+1.16%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

Great. Good morning, and welcome to the 40th Annual JPMorgan Healthcare Conference. My name is Cory Kasimov, I'm the senior large-cap biotech analyst, and it's my pleasure to introduce Gilead and Chairman and CEO, Daniel O'Day. (Operator Instructions)

So with that, Dan, thank you very much for being here. Always great speaking with you. Now let me hand things over to you for your presentation.

Daniel P. O;Day
Gilead Sciences, Inc. - Chairman & CEO

' -

Great. Well, thanks, Cory. I'm really pleased to be here today and representing the colleagues at Gilead. And I want to thank you, Cory, and everybody for the quick pivot to the virtual setting. And I know that's -- that was a heavy lift.

I want to start out by saying we are really looking forward to what promises to be another strong year for Gilead and frankly, a strong decade for Gilead. We're coming off a year of very positive momentum where we increased our full year total

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot